Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Alaunos Therapeutics, Inc.

Report preliminary Phase 1 data for CD19 CAR-T RPM

Not delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
14 Jan 2021
Due
31 Dec 2021
Checked
25 Oct 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“CD19 CAR-T RPM Autologous (Taiwan) Preliminary Ph 1 data H2 2021”

What we found

Evidence strength A What the grades mean

The company did not report preliminary Phase 1 data for the CD19 CAR-T RPM program by the H2 2021 deadline, as the joint venture responsible for the trial was dissolved in September 2021.

  • A
    Ziopharm Oncology Inc. 10-K filed 2022-03-30 Regulatory filing · published 30 Mar 2022 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint 575dbb4e7890
    “In September 2021, it was mutually agreed between the parties to dissolve the joint venture.” ✓ confirmed on the page

Checked 25 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
Preliminary Phase 1 data for CD19 CAR-T RPM
Where
Taiwan
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
  4. Third check on a negative finding: disagreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and read it as “no_evidence”, so a person decides.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Ziopharm Oncology Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-TCRT-022062 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.